CD74-NRG1 fusions, originally found in non-smoking lung adenocarcinoma patients, provide the ligand for ERBB2-ERBB3 receptor complexes through the extracellular expression of the EGF-like domain of NRG1 III-β3 [98]. The gene discussed is EGF; the disease is lung adenocarcinoma.